https://123dok.net/document/9ynm8e1z-efficacy-and-safety-of-the-fully-human-anti-tumour-necrosis-factor-alpha-monoclonal-antibody-adalimumab-d2e7-in-dmard-refractory-patients-with-rheumatoid-arthritis-a-12-week-phase-ii-study.html